ArticleScientific reports2025
Feasibility study of fracturing flowback fluid degradation by dielectric barrier discharge plasma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Fracturing flowback fluid, which is the waste fluid generated following the hydraulic fracturing of oil wells, has garnered significant attention in recent years regarding its safe treatment technologies. Low-temperature plasma water treatment technology is particularly notable for its high degradation efficiency and the environmentally benign by-products it produces. This study represents the inaugural application of dielectric barrier discharge (DBD) plasma for the degradation of fracturing flowback fluid. The research investigates the influence of varying voltages and initial pH on degradation efficiency, chemical oxygen demand (COD), pH, and viscosity of the flowback fluid. Furthermore, the mechanism of DBD plasma degradation of fracturing flowback fluid has been proposed. The findings indicate that the optimal parameters for DBD plasma degradation are as follows: a discharge voltage of 18 kV, a frequency of 10 kHz, a discharge duration of 120 min, and an initial solution pH of 7. Under these specified conditions, the degradation efficiency and COD of the flowback fluid were determined to be 71.41% and 104.00 mg/L, respectively. These results suggest that the degradation of fracturing flowback fluid via DBD plasma is a viable approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.